![Gregory Friberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Friberg
Net worth: 3 M $ as of 30/12/2025
Profile
Gregory R.
Friberg currently works at BioMarin Pharmaceutical, Inc., as Executive VP, Chief Research & Development Officer from 2024.
Dr. Friberg also formerly worked at Amgen, Inc., as Vice President-Global Development.
Dr. Friberg received his doctorate degree from New York Medical College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/09/2025 | 43,506 ( 0.02% ) | 3 M $ | 30/12/2025 |
Latest news about Gregory Friberg
Gregory Friberg active positions
| Companies | Position | Start |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 29/09/2024 |
Former positions of Gregory Friberg
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | - |
Training of Gregory Friberg
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Amgen, Inc.
 Amgen, Inc. Discovers, develops, manufactures and delivers human therapeutics | |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
New York Medical College
 New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Gregory Friberg
